Javier Suárez Alecha

Cirujano. Unidad de Coloproctología. Complejo Hospitalario de Navarra.

DATOS ACADEMICOS
Título de Licenciado en Medicina y Cirugía por la Universidad de Navarra, 1991.

SITUACIÓN PROFESIONAL ACTUAL
ORGANISMO: SISTEMA NAVARRO DE SALUD
CENTRO: COMPLEJO HOSPITALARIO DE NAVARRA
DEPT.: CIRUGÍA GENERAL

OTRAS  SITUACIONES
SITUACIÓN LABORAL: FUNCIONARIO ESTATUTARIO
DEDICACIÓN: TIEMPO COMPLETO

ACTIVIDADES ANTERIORES DE CARÁCTER CIENTÍFICO O PROFESIONAL
1993-1997: MIR - HOSPITAL UNIVERSITARIO VALL D´HEBRON (BARCELONA)
1998 -2001: ADJUNTO HOSPITAL UNIVERSITARIO VALL D´HEBRON
2001-2003: ADJUNTO HOSPITAL TXAGORRITXU (VITORIA)
2003 - FEA: COMPLEJO HOSPITALARIO DE NAVARRA

PUBLICACIONES

  1. Suárez J, Mearin F, Boque R, Zanón V, Armengol JR, Pradell J, et al. Laparoscopic myotomy vs endoscopic dilation in the treatment of achalasia. Surg Endosc. 2002;16(1):75-7.
  2. Balén E, Suárez J, Ariceta I, Oronoz B, Herrera J, Lera JM. Laparoscopic surgery in colorectal diseases. An Sist Sanit Navar. 2005;28 Suppl 3:67-80.
  3. Alecha JS, Ribera EB, Dorronsoro M, Ripa CZ, Cabezón JH, Tricas JM. Prognostic value of circumferential resection margin involvement in patients with locally-advanced rectal cancer. Cir Esp. 2007;81(1):18-22.
  4. Suárez J, Vera R, Balén E, Gómez M, Arias F, Lera JM, et al. Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer. Colorectal Dis. 2008;10(6):563-8.
  5. Súarez J, Jiménez J, Vera R, Tarifa A, Balén E, Arrazubi V, et al. Stent or surgery for incurable obstructive colorectal cancer: an individualized decision. Int J Colorectal Dis. 2010;25(1):91-6.
  6. Maas M, Nelemans PJ, Valentini V, Das P, Rödel C, Kuo LJ, et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol. 2010;11(9):835-44.
  7. Arraras JI, Suárez J, Arias de la Vega F, Vera R, Asín G, Arrazubi V, et al. The EORTC Quality of Life questionnaire for patients with colorectal cancer: EORTC QLQ-CR29 validation study for Spanish patients. Clin Transl Oncol. 2011;13(1):50-6.
  8. Suárez J, Amat I, Vera R, Balén E, Gómez M, Lera JM. Pathologic response of primary rectal cancer to oxaliplatin-based chemotherapy. Clin Colon Rectal Surg. 2011;24(2):119-24.
  9. Hernández-García I, Viúdez A, Suárez J, Arias De la Vega F, Vera R. Clinical complete response in locally advanced rectal cancer: can we offer a wait-and-see policy? Ann Oncol. 2013;24(3):853.
  10. Arrazubi V, Suárez J, Guerrero D, Gómez M, Viúdez A, Arias F, et al. Prognostic significance of thymidylate synthase polymorphisms in rectal cancer patients treated with neoadjuvant chemoradiotherapy. Colorectal Dis. 2013;15(4):428-35.
  11. Arraras JI, Suárez J, Arias-de-la-Vega F, Vera R, Ibáñez B, Asin G, et al. Quality of life assessment by applying EORTC questionnaires to rectal cancer patients after surgery and neoadjuvant and adjuvant treatment. Rev Esp Enferm Dig. 2013;105(5):255-61.
  12. Suarez J, Amoza S, Batlle X, Oronoz B, Balén E, Yarnoz C. Safety of Nonoperative Management  After Acute Diverticulitis. Ann Coloproctol 2014;30(5):216-221
  13. Maas M, Nelemans PJ, Valentini V, Crane CH, Capirci C, Rödel C, et al. Adjuvant chemotherapy in rectal cancer: defining subgroups who may benefit after neoadjuvant chemoradiation and resection: a pooled analysis of 3,313 patients. Int J Cancer. 2015;137(1):212-20.
  14. Suárez J, Marín G, Vera R, Oronoz B, Oteiza F, Mata E. Complications from the primary tumour are not related with survival in patients with synchronous stage IV colorectal cancer receiving chemotherapy without primary tumour resection. Int J Colorectal Dis. 2015;30(10):1357-63.
  15. Suárez J, Jimenez-Pérez J. Long-term outcomes after stenting as a "bridge to surgery" for the management of acute obstruction secondary to colorectal cancer. World J Gastrointest Oncol. 2016;8(1):105-12.
  16. Suárez J, Marín G, Vera R, Colibaseanu D, Vila JJ, Ciga MA, et al. Stent placement prior to initiation of chemotherapy in patients with obstructive, nonoperative left sided tumors is associated with fewer stomas. J Surg Oncol. 2017;115(7):856-863.
  17. Marin G, Suárez J, Vera R, Balén E, Viudez A, Mata E. Local recurrence after five years is associated with preoperative chemoradiotherapy treatment in patients diagnosed with stage II and III rectal cancer. Int J Surg. 2017;44:15-20.
  18. Balén E, Suárez J, Oronoz B, Lera JM. Continuous Gas Outflow is More Effective than Carbon Filters to Evacuate Smoke in laparoscopic Colorectal Resections: A Comparative Study. Surgical Science 2017;8(2):86-93.
Febrero
15
2018
16:00pm

Foro de debate sobre “Avances y retos actuales en la Enfermedad Inflamatoria Intestinal”

Pamplona, 15 de febrero de 2018 (16.00 - 20.00 h)

Lugar: Salón de actos del CIMA (Centro de Investigación Médica Aplicada) Universidad de Navarra (C/ Avda. Pío XII 55
Hora: 16.00-20.00
Coordinador: Jesús Honorato. Director del Aula de Innovación en Terapéutica Farmacológica.